{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T06:30:43Z","timestamp":1758349843469,"version":"3.44.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Tuberculosis (TB), caused by the <jats:italic>Mycobacterium tuberculosis<\/jats:italic> complex (MTBC), is the leading cause of death from a single infectious disease, despite being treatable. Global TB control efforts face significant challenges, including insufficient funding, ineffective vaccines, inadequate diagnostics, and complex treatments, particularly in resource-limited regions. West Africa has a unique TB epidemiology, characterized by medium- to high-prevalence rates and a greater diversity of the MTBC, which further compounds control efforts. In response to the global call to end TB by 2030, the West African Network of Excellence for TB, AIDS, and Malaria (WANETAM) has united scientists from 25 institutions across 12 West African countries to build research capacity and conduct translational research focused on TB. The multi-country program of WANETAM focuses on assisting the TB control programs of its member countries through the supply of essential laboratory equipment and the facilitation of laboratory accreditation\/certification (with three regional laboratories already ISO accredited and others on track). The program also emphasizes gender-sensitive training, the retention of critical laboratory and research expertise, improvements in the diagnosis of TB (including pediatric and drug-resistant forms), and conducting studies on TB to better understand the molecular epidemiology of the MTBC in the sub-region, thereby generating the evidence to inform the policy. To date, WANETAM has trained 13 postdoctoral fellows, 753 laboratory technicians\/technologists, and currently supports 7 female PhD students in the final year of their respective programs. By fostering collaboration among Francophone, Anglophone, and Lusophone West Africans, WANETAM is bridging cultural and language barriers to fight TB while also preparing West Africa for future pandemics.<\/jats:p>","DOI":"10.3389\/fpubh.2025.1590282","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T05:29:10Z","timestamp":1758259750000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Defying barriers to fight tuberculosis in West Africa: a model of equitable partnerships within a research capacity-strengthening network in the subregion"],"prefix":"10.3389","volume":"13","author":[{"given":"Isaac Darko","family":"Otchere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victory Fabian","family":"Edem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyin","family":"Togun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy","family":"Yeboah-Manu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Antonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the WANETAM-TB-Network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"volume-title":"Global tuberculosis report 2023","year":"2023","key":"ref1"},{"volume-title":"Global tuberculosis report 2020","year":"2020","key":"ref2"},{"volume-title":"Tuberculosis: factsheet. WHO news room","year":"2022","key":"ref3"},{"volume-title":"Global tuberculosis report 2024","year":"2024","key":"ref4"},{"volume-title":"The state of Food security and nutrition in the world 2023","year":"2023","key":"ref5"},{"volume-title":"Global hunger index: the power of youth in shaping food systems","year":"2023","author":"Von Grebmer","key":"ref6"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1056\/nejmp2118145","article-title":"Covid-19\u2019s devastating effect on tuberculosis care \u2014 a path to recovery","volume":"386","author":"Pai","year":"2022","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1371\/journal.pntd.0000744","article-title":"Mycobacterium africanum-review of an important cause of human tuberculosis in West Africa","volume":"4","author":"de Jong","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1073\/pnas.0511240103","article-title":"Variable host-pathogen compatibility in Mycobacterium tuberculosis","volume":"103","author":"Gagneux","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"864","DOI":"10.5588\/ijtld.14.0864","article-title":"Evaluation of GenoTypeW MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana","volume":"19","author":"Asante-Poku","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/IDR.S152720","article-title":"Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case","volume":"11","author":"Osei-Wusu","year":"2018","journal-title":"Infect Drug Resist"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e0004801","DOI":"10.1371\/journal.pntd.0004801","article-title":"Impact of the Mycobacterium africanum West Africa 2 lineage on TB diagnostics in West Africa: decreased sensitivity of rapid identification tests in the Gambia","volume":"10","author":"Ofori-Anyinam","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1099\/jmm.0.000846","article-title":"Low sensitivity of the MPT64 identification test to detect lineage 5 of the Mycobacterium tuberculosis complex","volume":"67","author":"Sanoussi","year":"2018","journal-title":"J Med Microbiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.46829\/hsijournal.2022.6.3.1.335-340","article-title":"Evaluation of a loop-mediated amplification test for rapid diagnosis of tuberculosis in Ghana","volume":"3","author":"Otchere","year":"2022","journal-title":"Heal Sci Investig J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijid.2024.01.003","article-title":"Diagnostic accuracy of Xpert MTB\/RIF ultra for childhood tuberculosis in West Africa \u2013 a multicenter pragmatic study","volume":"140","author":"Diallo","year":"2024","journal-title":"Int J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"CD009593","DOI":"10.1002\/14651858.CD009593.PUB4","article-title":"Xpert MTB\/RIF and Xpert MTB\/RIF ultra for pulmonary tuberculosis and rifampicin resistance in adults","volume":"6","author":"Horne","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3201\/eid1605.091262","article-title":"Extensively drug-resistant tuberculosis, Burkina Faso","volume":"16","author":"Saleri","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12916-016-0704-5","article-title":"The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance","volume":"14","author":"Gehre","year":"2016","journal-title":"BMC Med"},{"volume-title":"Global tuberculosis report 2015","year":"2015","key":"ref19"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2022.1069292","article-title":"Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases","volume":"13","author":"Otchere","year":"2023","journal-title":"Front Microbiol"},{"volume-title":"Global tubercolosis report 2018","year":"2018","key":"ref21"},{"volume-title":"Global Tuberculosis Report 2019","year":"2019","key":"ref22"},{"volume-title":"Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis","year":"2020","key":"ref23"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1038\/s41467-024-51266-0","article-title":"Genetic diversity within diagnostic sputum samples is mirrored in the culture of Mycobacterium tuberculosis across different settings","volume":"15","author":"Mariner-Llicer","year":"2024","journal-title":"Nat Commun"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/spectrum.01392-23","article-title":"A multifaceted interplay between virulence, drug resistance, and the phylogeographic landscape of Mycobacterium tuberculosis","volume":"11","author":"Mokrousov","year":"2023","journal-title":"Microbiol Spectr"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1016\/S2666-5247(21)00301-3","article-title":"The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis","volume":"3","author":"Walker","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1473-3099(15)00062-6","article-title":"Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study","volume":"15","author":"Walker","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1374703","DOI":"10.3389\/fpubh.2024.1374703","article-title":"Opinion review of drug resistant tuberculosis in West Africa: tackling the challenges for e ective control","volume":"12","author":"Otchere","year":"2024","journal-title":"Front Public Heal"},{"volume-title":"Global tuberculosis control 2010. Control WHO\/HTM\/TB, 218","year":"2010","key":"ref29"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1590282\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T05:29:12Z","timestamp":1758259752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1590282\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":29,"alternative-id":["10.3389\/fpubh.2025.1590282"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1590282","relation":{},"ISSN":["2296-2565"],"issn-type":[{"type":"electronic","value":"2296-2565"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"article-number":"1590282"}}